Abstract |
The clinical study on the Romanian product Trofopar was performed on 71 patients affected by chronic liver diseases; of them 30 patients suffered from cirrhosis decompensated at the parenchymal and vascular level. The clinical results corroborated with laboratory tests substantiate the efficacy of Trofopar, which improves liver blood circulation, increases the capacity of hepatocyte regeneration, detoxification and metabolization.
|
Authors | A S Loghinov, G V Suhareva, E A Bendikov, I E Blok, C J Astasenkova, A P Nicolaeva |
Journal | Romanian journal of internal medicine = Revue roumaine de medecine interne
(Rom J Intern Med)
1991 Jan-Jun
Vol. 29
Issue 1-2
Pg. 65-74
ISSN: 1220-4749 [Print] Germany |
PMID | 1947713
(Publication Type: Clinical Trial, Comparative Study, Journal Article)
|
Chemical References |
- Peptides
- trofopar
- Leucine
- Antipyrine
|
Topics |
- Adolescent
- Adult
- Aged
- Antipyrine
- Chronic Disease
- Female
- Hepatitis, Chronic
(blood, drug therapy)
- Humans
- Leucine
(blood, drug effects)
- Liver Cirrhosis
(blood, drug therapy)
- Liver Diseases
(blood, drug therapy)
- Male
- Middle Aged
- Peptides
(therapeutic use)
- Remission Induction
|